Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 5, 2007

View Archived Issues

Trial finds hMaxi-K gene transfer safe in erectile dysfunction patients

Major bear bile component may be useful to prevent retinal degeneration

MVA-BN-HER-2 breast cancer vaccine cleared for clinical trials

Cytokinetics and Amgen form strategic alliance in heart failure

Ozarelix cleared for phase IIb study in BPH

Development plans updated for CPP-109 in drug addiction

Antigen challenge study of Aerovant in asthma meets endpoints

IMC-3G3 begins phase I study in solid tumors

Warner Chilcott and Foamix to develop antibiotic foam for acne

Sigma-Aldrich grants Pfizer research license to utilize ddRNAi technology

Reolysin to be studied with gemcitabine in advanced cancers

bioMerieux and ExonHit target prostate cancer in new screening program

Roche and Synosis to explore drugs' potential for CNS disorders

QLT receives final payment for generic derma and manufacturing business

Genaera ends Evizon program and restructures

ARC-1779 begins phase I program

Medivir files to begin phase I trials of cathepsin K inhibitor MIV-701

Rotigotine patch effective for early-stage Parkinson's disease

Merck KGaA patents novel tyrosinase inhibitors

Novel antiinflammatory agents described in recent patents

Recent patents report discovery of novel oncolytic drugs

Alimta approved for malignant pleural mesothelioma in Japan

Pivotal study of ipilimumab in metastatic melanoma completes enrollment

Pivotal study under way for Allovectin-7 in metastatic melanoma

Enrollment begins in phase II trial of rNAPc2 in metastatic colorectal carcinoma

Biogen Idec to acquire Syntonix

New phase II study investigates 6R-BH4 in symptomatic peripheral arterial disease

Testosterone gel for Alzheimer's disease / News in Context

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...